Clinical Trial Update: Neoadjuvant TCHP Versus THP in Patients With HER2-positive Breast Cancer (neoCARHP Study) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing neoadjuvant TCHP versus THP in HER2-positive breast cancer (neoCARHP); status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TCHP
• THP

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Neoadjuvant Therapies for HER2+ Breast Cancer | Phase 3 | Status: UNKNOWN